Nanomaterials in targeting amyloid-β oligomers: current advances and future directions for Alzheimer's disease diagnosis and therapy

• Shiwani Randhawa,
• Trilok Chand Saini,
• Manik Bathla,
• Rahul Bhardwaj,
• Rubina Dhiman and
• Amitabha Acharya

Beilstein J. Nanotechnol. 2025, 16, 561–580, doi:10.3762/bjnano.16.44

• progression of AD [10]. Numerous studies have indicated a strong association between neuronal dysfunction and the presence of oligomeric species. Researchers are increasingly coming to a consensus that the neurotoxicity observed in neurodegenerative diseases (NDs) is not attributable to a single, isolated

• improved associated neurotoxicity [52]. Shifting from imaging to electrochemical approaches, researchers have developed biosensors comprising immobilized thiolated PrPC peptides on a graphene oxide/gold nanoparticle hydrogel electrode. This nanobiosensor displayed high specificity and sensitivity for

• characteristics enable specific interactions with amyloid fibrils, effectively inhibiting oligomerization and reducing neuronal cell death. Moreover, these NPs can be functionalized with targeted ligands, enhancing their selectivity and efficacy in therapeutic applications aimed at Aβ-induced neurotoxicity

Therapeutic effect of F127-folate@PLGA/CHL/IR780 nanoparticles on folate receptor-expressing cancer cells

• Thi Ngoc Han Pham,
• Phuong-Thao Dang-Luong,
• Hong-Phuc Nguyen,
• Loc Le-Tuan,
• Xuan Thang Cao,
• Thanh-Danh Nguyen,
• Vy Tran Anh and
• Hieu Vu_Quang

Beilstein J. Nanotechnol. 2024, 15, 954–964, doi:10.3762/bjnano.15.78

• consequently disrupting DNA replication in proliferating cancer cells. The neurotoxicity and myelotoxicity of CHL, however, limit its clinical use [20][21]. Moreover, the instability of chemotherapeutics due to the hydrolysis of the chloroethyl group significantly hampers their therapeutic impact [22

On the additive artificial intelligence-based discovery of nanoparticle neurodegenerative disease drug delivery systems

• Shan He,
• Julen Segura Abarrategi,
• Harbil Bediaga,
• Sonia Arrasate and
• Humberto González-Díaz

Beilstein J. Nanotechnol. 2024, 15, 535–555, doi:10.3762/bjnano.15.47

• coworkers. These researchers employed this database to create advanced predictive models known as multitarget or multiplexing QSAR. These models are designed to forecast both the potential neurotoxicity and neuroprotective effects of drugs across various experimental setups, including multiple assays, drug

Classification and application of metal-based nanoantioxidants in medicine and healthcare

• Nguyen Nhat Nam,
• Nguyen Khoi Song Tran,
• Tan Tai Nguyen,
• Nguyen Ngoc Trai,
• Nguyen Phuong Thuy,
• Hoang Dang Khoa Do,
• Nhu Hoa Thi Tran and
• Kieu The Loan Trinh

Beilstein J. Nanotechnol. 2024, 15, 396–415, doi:10.3762/bjnano.15.36

• to biological systems can cause detrimental effects on human health. Sobolewski et al. confirmed the Fe2O3 nanoparticles with sizes between 11.2 and 13.6 nm can lead to oxidative damage and neurotoxicity in the mouse brain [189]. Meanwhile, the rapid clearance of SiNPs from blood depletes plasma

Transient coating of γ-Fe₂O₃ nanoparticles with glutamate for its delivery to and removal from brain nerve terminals

• Konstantin Paliienko,
• Artem Pastukhov,
• Michal Babič,
• Daniel Horák,
• Olga Vasylchenko and
• Tatiana Borisova

Beilstein J. Nanotechnol. 2020, 11, 1381–1393, doi:10.3762/bjnano.11.122

• established [41]. Also, an increase in glutamate concentration in blood plasma after stroke episodes was found [42]. In this context, even a low efficacy of γ-Fe2O3 nanoparticles to adsorb glutamate can be used for the prevention of neurotoxicity in the blood and also in the brain and peripheral nervous

Development of polycationic amphiphilic cyclodextrin nanoparticles for anticancer drug delivery

• Gamze Varan,
• Juan M. Benito,
• Carmen Ortiz Mellet and
• Erem Bilensoy

Beilstein J. Nanotechnol. 2017, 8, 1457–1468, doi:10.3762/bjnano.8.145

• Cremophor EL®, which is known to be the cause of severe side effects including nephrotoxicity, neurotoxicity and hypersensitivity reactions [5][6]. Other major problems encountered in the clinical administration of PCX are rapid recrystallization of the drug as a result of dilution in isotonic saline or

Needs and challenges for assessing the environmental impacts of engineered nanomaterials (ENMs)

• Michelle Romero-Franco,
• Hilary A. Godwin,
• Muhammad Bilal and
• Yoram Cohen

Beilstein J. Nanotechnol. 2017, 8, 989–1014, doi:10.3762/bjnano.8.101

• also evaluated based on answers to questions about the ENM aspect ratio (e.g., a high aspect ratio ENM is categorized immediately as high), evidence of adverse outcomes related to acute and chronic effect posed by the ENM (e.g., evidence to support genotoxicity, neurotoxicity, carcinogenicity, and/or

Unraveling the neurotoxicity of titanium dioxide nanoparticles: focusing on molecular mechanisms

• Bin Song,
• Yanli Zhang,
• Jia Liu,
• Xiaoli Feng,
• Ting Zhou and
• Longquan Shao

Beilstein J. Nanotechnol. 2016, 7, 645–654, doi:10.3762/bjnano.7.57

• and are widely used in many fields. Numerous in vivo studies, exposing experimental animals to these NPs through systematic administration, have suggested that TiO2 NPs can accumulate in the brain and induce brain dysfunction. Nevertheless, the exact mechanisms underlying the neurotoxicity of TiO2 NPs

• signaling pathways, dysregulated neurotransmitters and synaptic plasticity have also been shown to contribute to neurotoxicity of TiO2 NPs. Recently, studies on autophagy and DNA methylation have shed some light on possible mechanisms of nanotoxicity. Therefore, we offer a new perspective that autophagy and

• DNA methylation could contribute to neurotoxicity of TiO2 NPs. Undoubtedly, more studies are needed to test this idea in the future. In short, to fully understand the health threats posed by TiO2 NPs and to improve the bio-safety of TiO2 NPs-based products, the neurotoxicity of TiO2 NPs must be

Release behaviour and toxicity evaluation of levodopa from carboxylated single-walled carbon nanotubes

• Julia M. Tan,
• Jhi Biau Foo,
• Sharida Fakurazi and
• Mohd Zobir Hussein

Beilstein J. Nanotechnol. 2015, 6, 243–253, doi:10.3762/bjnano.6.23

• well-described by a pseudo-second-order kinetic model. A cytotoxicity assay of the synthesized nanohybrid was also carried out in PC12 cell lines (a widely used, in vitro Parkinson’s model for neurotoxicity studies) using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay in order

PVP-coated, negatively charged silver nanoparticles: A multi-center study of their physicochemical characteristics, cell culture and in vivo experiments

• Sebastian Ahlberg,
• Alexandra Antonopulos,
• Jörg Diendorf,
• Ralf Dringen,
• Matthias Epple,
• Rebekka Flöck,
• Wolfgang Goedecke,
• Christina Graf,
• Nadine Haberl,
• Jens Helmlinger,
• Fabian Herzog,
• Frederike Heuer,
• Stephanie Hirn,
• Christian Johannes,
• Stefanie Kittler,
• Manfred Köller,
• Katrin Korn,
• Wolfgang G. Kreyling,
• Fritz Krombach,
• Jürgen Lademann,
• Kateryna Loza,
• Eva M. Luther,
• Marcelina Malissek,
• Martina C. Meinke,
• Daniel Nordmeyer,
• Anne Pailliart,
• Jörg Raabe,
• Fiorenza Rancan,
• Barbara Rothen-Rutishauser,
• Eckart Rühl,
• Carsten Schleh,
• Andreas Seibel,
• Christina Sengstock,
• Lennart Treuel,
• Annika Vogt,
• Katrin Weber and
• Reinhard Zellner

Beilstein J. Nanotechnol. 2014, 5, 1944–1965, doi:10.3762/bjnano.5.205

• and/or intracellular dissolution of silver nanoparticles to silver ions. Silver nanoparticles and brain cells (astrocytes) Silver nanoparticles have been reported to damage the blood–brain barrier, to enter the brain and to cause neurotoxicity [96][97][98]. In addition, once nanoparticles have entered

Manipulation of isolated brain nerve terminals by an external magnetic field using D-mannose-coated γ-Fe₂O₃ nano-sized particles and assessment of their effects on glutamate transport

• Tatiana Borisova,
• Natalia Krisanova,
• Arsenii Borуsov,
• Roman Sivko,
• Ludmila Ostapchenko,
• Michal Babic and
• Daniel Horak

Beilstein J. Nanotechnol. 2014, 5, 778–788, doi:10.3762/bjnano.5.90

• introduction, a certain level of ambient glutamate is very important for normal synaptic transmission, whereas even a small increase in this level causes neurotoxicity. Nowadays, it is suggested that in unstimulated nerve terminals glutamate enriches the extracellular space by spontaneous exocytosis, and

Modulation of defect-mediated energy transfer from ZnO nanoparticles for the photocatalytic degradation of bilirubin

• Tanujjal Bora,
• Karthik K. Lakshman,
• Soumik Sarkar,
• Abhinandan Makhal,
• Samim Sardar,
• Samir K. Pal and
• Joydeep Dutta

Beilstein J. Nanotechnol. 2013, 4, 714–725, doi:10.3762/bjnano.4.81

• small portion is excreted in the urine [2]. Excess bilirubin in blood can lead to deposits on tissues, which gives rise to neurotoxicity and hyperbilirubinemia and/or a yellowish pigmentation of the skin, a disease commonly known as jaundice. According to the World Health Organization, almost 30,000